0 0 Dr Szychot Paediatric Oncology Limited 13850030 false 2024-02-01 2025-03-31 2025-03-31 The principal activity of the company is that of specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 13850030 2024-02-01 2025-03-31 13850030 2025-03-31 13850030 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13850030 bus:Micro-entities 2024-02-01 2025-03-31 13850030 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-03-31 13850030 bus:FilletedAccounts 2024-02-01 2025-03-31 13850030 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-03-31 13850030 bus:RegisteredOffice 2024-02-01 2025-03-31 13850030 bus:Director1 2024-02-01 2025-03-31 13850030 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-03-31 13850030 countries:EnglandWales 2024-02-01 2025-03-31 13850030 2023-02-01 2024-01-31 13850030 2024-01-31 13850030 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 xbrli:pure iso4217:GBP

Registration number: 13850030

Dr Szychot Paediatric Oncology Limited

Unaudited Financial Statements

for the Period from 1 February 2024 to 31 March 2025

 

Dr Szychot Paediatric Oncology Limited

Statement of Financial Position as at 31 March 2025

2025
£

2024
£

Fixed assets

450

-

Current assets

16,085

839

Prepayments and accrued income

-

993

Creditors: Amounts falling due within one year

(3,641)

(783)

Net current assets

12,444

1,049

Total assets less current liabilities

12,894

1,049

Accruals and deferred income

(960)

(960)

 

11,934

89

Capital and reserves

11,934

89

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
c/o Brebners
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

2

Basis of Preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

3

Staff numbers

The average number of persons employed by the company during the period was 0 (2024 - 0).

 

Dr Szychot Paediatric Oncology Limited

Statement of Financial Position as at 31 March 2025

For the financial period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the director on 5 November 2025
 

.........................................
Dr E Szychot
Director

   
     

Company registration number: 13850030